That's really not how it works. The FDA is fundamentally concerned about two things, safety and efficacy. You need a plan to demonstrate the latter, and you need your quality system, SDP, etc. to demonstrate how you approach the former. This is about good engineering practices, not particular implementation techniques.
So you can do things many different ways. If you do say "we do this like X, which is industry standard, just like T, U, and V do" it's a simpler argument than "we do this like Y. Lots of people do X, but here is how we have demonstrated Y is better for us...". But this can be fine too, just possibly more work.
Also worth noting (a) there is no industry-wide best practices agreement (b) there is no FDA wide agreement on what should be done (different device types are reviewed by different panels (c) the FDA doesn't understand software development deeply across it's panels, but it is catching up.